YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK .0001 g/100g
CAFFEINE 0.5% Mu-conotoxin CnIIIC 0.0001% ELASTIN 0.009% UBIQUINONE 0.02% · CREAM · Guangdong Joyan Biological Technology Co.,Ltd
YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK is a cream containing caffeine 0.5% mu-conotoxin cniiic 0.0001% elastin 0.009% ubiquinone 0.02% at .0001 g/100g, taken topical. Manufactured by Guangdong Joyan Biological Technology Co.,Ltd.
Key Facts
- Brand Name
- YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK
- Generic Name
- CAFFEINE 0.5% Mu-conotoxin CnIIIC 0.0001% ELASTIN 0.009% UBIQUINONE 0.02%
- NDC Code (Product)
85779-002- Manufacturer
- Guangdong Joyan Biological Technology Co.,Ltd
- Strength
- .0001 g/100g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Drug Class
- Central Nervous System Stimulant [EPC]; Methylxanthine [EPC]
- Marketing Start
- 06/10/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK used for?
YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK contains CAFFEINE 0.5% Mu-conotoxin CnIIIC 0.0001% ELASTIN 0.009% UBIQUINONE 0.02%. It is a cream taken topical. Consult your doctor for specific uses.
Is YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK a controlled substance?
YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK is not classified as a controlled substance by the DEA.
What is the generic name for YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK?
The generic name for YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK is CAFFEINE 0.5% Mu-conotoxin CnIIIC 0.0001% ELASTIN 0.009% UBIQUINONE 0.02%. There are no other listed brand versions of CAFFEINE 0.5% Mu-conotoxin CnIIIC 0.0001% ELASTIN 0.009% UBIQUINONE 0.02%.
What is the NDC code for YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK .0001 g/100g?
The NDC (National Drug Code) for YVES CONOPEPTIDE LUXURY TIGHTEN CREME EYE MASK .0001 g/100g is 85779-002, listed by Guangdong Joyan Biological Technology Co.,Ltd.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)